Clinical Trial Update: Bioequivalence Study of Dronedarone Hydrochloride Tablets [NA]

View source ↗

Summary

A completed bioequivalence study of dronedarone hydrochloride tablets for atrial fibrillation has been reported. The trial was sponsored by Shandong New Time Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dronedarone hydrochloride tablets (dronedarone hydrochloride)

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Atrial Fibrillation (AF) | NA | Status: COMPLETED